Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis

Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence

(2010) V E Mulanovich et al.   BONE MARROW TRANSPLANTATION

Optimization of endochin-like quinolones for antimalarial activity

(2010) Rolf Winter et al.   EXPERIMENTAL PARASITOLOGY

Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

(2010) Sibylle Winterhalter et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

In Vitro and In Vivo Activities of 1-Hydroxy-2-Alkyl-4(1H)Quinolone Derivatives against Toxoplasma gondii

(2009) L. L. Bajohr et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone

(2008) P. Meneceur et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The History ofToxoplasma gondii—The First 100 Years

(2008) JITENDER P. DUBEY   JOURNAL OF EUKARYOTIC MICROBIOLOGY

Mutations in cytochrome b that affect kinetics of the electron transfer reactions at center N in the yeast cytochrome bc1 complex

(2007) Frederik A.J. Rotsaert et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Antimalarial quinolones: Synthesis, potency, and mechanistic studies

(2007) Rolf W. Winter et al.   EXPERIMENTAL PARASITOLOGY